Tilray (TLRY) Medical, a division of Tilray Brands, announced significant updates to its Tilray Medical pricing programs in Canada. These changes are designed to make medical cannabis more accessible for patients nationwide. As part of these updates, Tilray Medical’s Compassionate Pricing program now features an increased annual income eligibility threshold of $65,000 CAD, up from $32,500 CAD, ensuring more patients qualify for support.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLRY:
- Tilray’s Tumultuous Week: Stock Dips Amid Mixed Signals
- Moderately bullish activity in Tilray with shares up 2.71%
- Mixed options sentiment in Tilray with shares down 2.21%
- Tilray to debut brands at American Craft Beer Experience Festival in Japan
- Mixed options sentiment in Tilray with shares down 1.81%